Masimo Appoints Tim Benner as President to Lead Next Phase of Growth and Innovation
Masimo, a Danaher company recognized globally for its innovations in pulse oximetry, patient monitoring technologies, and specialty diagnostic solutions, has announced the appointment of Tim Benner as President, effective August 3, 2026. The leadership transition marks an important milestone for the company as it continues integrating into Danaher’s global healthcare portfolio while expanding its position in advanced patient monitoring and diagnostic technologies.
Benner’s appointment comes after more than a year of leadership within Masimo, during which he played a central role in shaping the company’s commercial strategy, strengthening customer engagement, and supporting the organization’s transition following Danaher’s acquisition. His promotion reflects confidence from both Masimo and Danaher executives in his ability to guide the organization through its next phase of innovation, operational excellence, and global growth.
With more than three decades of executive leadership experience across the medical technology industry, Benner brings extensive expertise in commercial strategy, product innovation, customer relationships, and organizational leadership. As President, he will oversee Masimo’s worldwide operations, drive continued innovation across its patient monitoring portfolio, and help accelerate the company’s mission of improving healthcare outcomes through advanced medical technologies.
A New Chapter Following Danaher’s Acquisition
The appointment represents an important development in Masimo’s ongoing transformation following its acquisition by Danaher.
Since becoming part of Danaher, Masimo has been working to integrate its expertise in noninvasive patient monitoring with Danaher’s global healthcare capabilities, operational excellence, and innovation ecosystem.
The transition aims to strengthen Masimo’s ability to expand its technological leadership while maintaining the entrepreneurial culture and customer focus that have defined the company for more than three decades.
Benner has been closely involved in this transition from its early stages, helping align commercial strategies, strengthen customer relationships, and position the organization for sustainable long-term growth.
His elevation to President reflects continuity in leadership during a period of significant organizational evolution.
Leadership Progression Within Masimo
Since joining Masimo in June 2025, Tim Benner has held several increasingly influential executive positions.
Initially serving as Chief Marketing and Strategy Officer, he helped define the company’s strategic direction while overseeing marketing initiatives and long-term growth planning.
He later assumed the role of Chief Commercial Officer, where he became responsible for leading Masimo’s worldwide commercial organization.
In that capacity, he oversaw:
- Global sales operations
- Commercial strategy
- Customer engagement
- Marketing
- Strategic growth initiatives
- Business development
- Market expansion efforts
These responsibilities placed him at the center of Masimo’s customer-facing operations during one of the company’s most important periods of organizational transition.
His experience across multiple executive functions has provided a comprehensive understanding of the company’s operations, technologies, customers, and long-term strategic priorities.
Confidence from Danaher Leadership
Julie Sawyer Montgomery, CEO Designate of Danaher Corporation, emphasized Benner’s contributions to Masimo and expressed confidence in his ability to lead the company into its next stage of development.
She noted that Benner has played an integral role in positioning Masimo for long-term success through strategic leadership, customer focus, and a commitment to innovation.
According to Montgomery, his deep understanding of both customer needs and healthcare technology makes him well suited to guide Masimo as it continues expanding within Danaher’s global life sciences and diagnostics portfolio.
The appointment also reflects Danaher’s broader emphasis on developing experienced leaders capable of driving innovation while maintaining operational excellence across its businesses.
More Than Three Decades of Medical Technology Leadership
Tim Benner brings over 30 years of executive leadership experience spanning several of the world’s leading medical technology companies.
Throughout his career, he has held senior leadership positions involving:
- Commercial operations
- Corporate strategy
- Marketing
- Product management
- Business development
- Organizational transformation
- Global market expansion
His experience includes leadership roles at several major healthcare organizations, including:
- Edwards Lifesciences
- Abbott
- Terumo
- Inari Medical
- Stryker
- Masimo
Working across these organizations has given Benner broad exposure to multiple areas of medical technology, including cardiovascular care, critical care, interventional medicine, diagnostics, and patient monitoring.
Building High-Performing Organizations
A consistent theme throughout Benner’s career has been the development of high-performing commercial organizations.
His leadership has focused on creating customer-centered teams capable of delivering innovative medical technologies while maintaining strong partnerships with healthcare providers.
Building effective commercial organizations involves more than sales performance.
It also requires:
- Customer education
- Clinical support
- Market development
- Cross-functional collaboration
- Strategic planning
- Talent development
- Operational excellence
These capabilities become particularly important as healthcare systems increasingly evaluate technologies based not only on clinical performance but also on value, efficiency, and patient outcomes.
Advancing Innovation in Healthcare
Innovation has long been central to Masimo’s corporate identity.
Since its founding, the company has pioneered numerous advances in noninvasive monitoring technologies that have transformed patient care worldwide.
Masimo’s innovations include technologies supporting:
- Pulse oximetry
- Continuous oxygen saturation monitoring
- Patient safety
- Critical care
- Hospital monitoring
- Remote patient monitoring
- Specialty diagnostics
The company has become widely recognized for developing technologies designed to improve clinical decision-making while enhancing patient safety across hospitals, surgical centers, emergency departments, and outpatient settings.
As President, Benner will oversee continued investment in these innovation efforts while supporting the development of future diagnostic and monitoring solutions.
Combining Innovation with the Danaher Business System
In accepting the role, Benner emphasized the unique opportunities created through Masimo’s integration into Danaher.
He noted that Masimo has earned the trust of clinicians worldwide through more than three decades of breakthrough innovation focused on improving patient care.
According to Benner, becoming part of Danaher provides an opportunity to build upon that legacy by combining Masimo’s culture of scientific innovation with the proven operational excellence of the Danaher Business System (DBS).
The Danaher Business System serves as the company’s operating philosophy for driving continuous improvement across every aspect of business operations.
The system emphasizes:
- Customer focus
- Continuous improvement
- Data-driven decision-making
- Lean operational practices
- Innovation
- Quality
- Team development
By integrating DBS principles with Masimo’s technical expertise, the organization aims to accelerate innovation while enhancing operational efficiency.
Continuing Masimo’s Mission
Throughout its history, Masimo has remained committed to improving patient outcomes through advanced monitoring technologies.
Many of the company’s products help clinicians obtain more accurate physiological measurements that support earlier diagnosis, better treatment decisions, and improved patient safety.
These technologies are used across numerous healthcare environments, including:
- Intensive care units
- Operating rooms
- Emergency departments
- Neonatal care
- General hospital wards
- Ambulatory care settings
- Home monitoring
As healthcare increasingly embraces digital technologies, remote monitoring, and data-driven clinical decision support, Masimo continues expanding its capabilities to meet evolving healthcare needs.
Responsibilities as President
As President, Benner will oversee Masimo’s global business operations.
His responsibilities include leading initiatives focused on:
- Product innovation
- Commercial growth
- Customer partnerships
- Strategic planning
- Global market expansion
- Organizational leadership
- Operational performance
- Business integration
He will also guide continued investment in the company’s patient monitoring technologies while helping strengthen relationships with healthcare providers, hospitals, distributors, and clinical partners worldwide.
These responsibilities position him to influence nearly every aspect of Masimo’s future development.
Strengthening Customer Relationships
One of Benner’s major priorities is expected to involve expanding customer engagement.
Healthcare providers increasingly seek technology partners capable of delivering not only innovative products but also comprehensive support, education, clinical expertise, and long-term collaboration.
Building strong customer relationships helps organizations better understand evolving clinical needs while supporting product development aligned with real-world healthcare challenges.
Benner has consistently emphasized customer-centered leadership throughout his career, making this an important component of Masimo’s future strategy.
Expanding Commercial Growth
Global demand for advanced patient monitoring continues to increase.
Factors contributing to market growth include:
- Aging populations
- Rising chronic disease prevalence
- Increased surgical volumes
- Expansion of outpatient care
- Greater emphasis on patient safety
- Growth in remote monitoring
- Digital healthcare transformation
Masimo is positioned to benefit from these long-term industry trends by continuing to expand its monitoring portfolio and introducing new technologies supporting clinicians across multiple care settings.
Commercial expansion remains an important strategic priority as the company seeks to strengthen its global market presence.
Supporting Healthcare Professionals Worldwide
Masimo technologies are used by clinicians around the world to support patient care.
The company’s products assist healthcare professionals by providing reliable physiological measurements that help guide treatment decisions in both routine and critical care settings.
Accurate patient monitoring contributes to:
- Earlier detection of deterioration
- Improved patient safety
- Better treatment decisions
- Enhanced workflow efficiency
- Reduced clinical uncertainty
Continued innovation in these areas remains central to Masimo’s mission of improving healthcare delivery globally.
Positioning for Future Growth
Healthcare technology continues evolving rapidly through advances in artificial intelligence, connected medical devices, predictive analytics, cloud-based monitoring, and digital health integration.
Patient monitoring systems are expected to become increasingly intelligent, interoperable, and capable of supporting personalized care.
Masimo’s combination of engineering expertise, clinical research, and global commercial capabilities positions the company to participate actively in these evolving healthcare trends.
Under Benner’s leadership, the organization is expected to continue investing in innovation while expanding opportunities for long-term sustainable growth.
Tim Benner’s appointment as President marks an important leadership transition for Masimo as the company enters its next phase under Danaher’s ownership. Drawing upon more than 30 years of executive experience in the medical technology industry, Benner brings a combination of commercial expertise, strategic vision, and customer-focused leadership that aligns with Masimo’s long-standing mission of advancing patient care through innovation.
Having already played a critical role in guiding the company’s strategic direction, strengthening customer relationships, and supporting its successful integration into Danaher, Benner is well positioned to lead Masimo’s continued growth. As President, he will oversee global operations, accelerate innovation across the patient monitoring portfolio, expand commercial opportunities, and build upon the company’s reputation for delivering breakthrough technologies that improve clinical outcomes for patients worldwide.
Source link: https://www.masimo.com/
